局部镇痛药市场规模、份额和增长分析（按治疗分类、剂型、性别、年龄组、类型、分销渠道和地区划分）－2026-2033年行业预测

预计到 2024 年，全球局部止痛药市场规模将达到 120.2 亿美元，到 2025 年将达到 129 亿美元，到 2033 年将达到 226.6 亿美元，预测期（2026-2033 年）的复合年增长率为 7.3%。

关节炎盛行率的不断上升显着推动了全球外用止痛药市场的收入成长。此外，人口老化加剧以及运动员的高需求也促进了这个市场的发展。该市场的特点在于对细分市场、发展趋势、驱动因素和竞争动态的全面分析。糖尿病神经病变和癌症相关疼痛等发生率的上升也进一步扩大了市场机会。与口服药物相比，外用解决方案的副作用较少，因此更受青睐。然而，潜在的皮肤刺激和难闻的气味等挑战可能会阻碍市场成长。同时，线上平台的兴起和新兴市场的成长为市场扩张提供了充满希望的途径，凸显了塑造外用止痛药市场的挑战与机会之间复杂的平衡关係。

全球局部止痛药市场驱动因素

慢性疼痛疾病（包括关节炎、肌肉骨骼疾病和神经病变疼痛）的日益普遍，是推动局部止痛药需求成长的主要因素。越来越多的人寻求有效、局部的疼痛管理方案，既方便又能精准缓解疼痛。这一趋势反映了消费者偏好的转变，他们希望找到一种能够轻鬆应用于特定疼痛部位的治疗方法，从而提高整体止痛效果。随着人们对这些疾病的认识不断提高，局部止痛药市场持续扩张，以满足人们对快速起效、便捷止痛方案的不断增长的需求。

限制全球局部止痛药市场的因素

由于缺乏全面的临床证据支持其疗效和安全性，全球外用止痛药市场面临严峻挑战。这种证据的匮乏会削弱消费者的信任，阻碍产品的普及，因为潜在使用者在缺乏严谨研究的实证支持时，可能不愿意依赖这些产品。因此，外用止痛药疗效和安全性的不确定性限制了消费者和医疗保健提供者对其的接受度，并严重阻碍因素了该细分市场的成长和扩张。弥合这一差距对于建立信任和促进产品普及至关重要。

全球局部镇痛药市场趋势

全球局部止痛药市场正呈现出明显的趋势，即越来越多地采用天然草本成分，这反映出消费者对健康保健类产品的偏好日益增长。随着消费者对合成替代品的认知度下降，他们对利用植物成分（以其止痛和抗发炎功效而闻名）的配方需求不断增加。这种转变源自于消费者对更安全、化学成分更少的产品的偏好，迫使製造商不断创新并拓展产品线。因此，市场正在朝着更重视透明度、原料来源和永续性的方向发展，这与更广泛的消费者健康趋势相符。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 客户和购买标准分析
• 监管分析

全球局部止痛药市场规模（依治疗类别划分）及复合年增长率（2026-2033 年）

• 非阿片类药物
  • 非类固醇消炎剂（NSAIDs）
  • 水杨酸甲酯
  • 辣椒素
  • Lidocaine
  • 其他非鸦片类药物
• 阿片类药物
  • Buprenornhine
  • Fentanyl

全球局部止痛药市场规模（依剂型及复合年增长率划分）（2026-2033 年）

• 奶油
• 凝胶
• 喷
• 修补
• 其他的

全球局部止痛药市场规模（按性别划分）及复合年增长率（2026-2033 年）

• 女士
• 男性

全球局部止痛药市场规模（依年龄层划分）及复合年增长率（2026-2033 年）

• 成年人（18-64岁）
• 老年人（65岁以上）

全球局部止痛药市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 处方笺止痛药
• 非处方止痛药

全球局部止痛药市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 药房和药品商店
• 零售店
• 网路商店

全球局部止痛药市场规模（按地区划分）及复合年增长率（2026-2033 年）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Johnson & Johnson（United States）
• GlaxoSmithKline plc（United Kingdom）
• Novartis AG（Switzerland）
• Pfizer Inc.（United States）
• Reckitt Benckiser Group plc（United Kingdom）
• Sun Pharmaceutical Industries Ltd.（India）
• Endo International plc（Ireland）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Sanofi SA（France）
• Mylan NV（now part of Viatris Inc.）（United States）
• AdvaCare Pharma（United States）
• Topical Biomedics Inc.（United States）

结论与建议

Global Topical Pain Relief Market size was valued at USD 12.02 Billion in 2024 and is poised to grow from USD 12.9 Billion in 2025 to USD 22.66 Billion by 2033, growing at a CAGR of 7.3% during the forecast period (2026-2033).

The growing prevalence of arthritis significantly drives revenue growth in the global topical pain relief market. Additionally, the increasing elderly population and high demand among athletes contribute to this expansion. The market is characterized by a thorough analysis of segments, trends, drivers, and competitive dynamics. Factors such as rising cases of diabetic neuropathy and cancer-related pain further enhance market opportunities. The shift toward topical solutions is favored due to their reduced side effects compared to oral medications. Nonetheless, challenges like potential skin irritation and unpleasant odors can hinder growth. In contrast, the rise of online platforms and emerging markets present exciting avenues for expansion, highlighting the intricate balance of challenges and opportunities shaping the topical pain relief landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Topical Pain Relief market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Topical Pain Relief Market Segments Analysis

Global Topical Pain Relief Market is segmented by Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel and region. Based on Therapeutic Classes, the market is segmented into Non-opioids and Opioids. Based on Formulation, the market is segmented into Cream, Gel, Spray, Patch and Others. Based on Gender, the market is segmented into Women and Men. Based on Age Group, the market is segmented into Adults (18-64 Years) and Geriatric (65 Years and Above). Based on Type, the market is segmented into Prescription Pain Relief and Over the Counter (OTC) Pain Relief. Based on Distribution Channel, the market is segmented into Pharmacy and Drug Stores, Retail Stores and Online Stores. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Topical Pain Relief Market

The growing prevalence of chronic pain conditions, including arthritis, musculoskeletal disorders, and neuropathic pain, significantly fuels the demand for topical pain relief options. Individuals are increasingly looking for effective localized pain management solutions that provide both convenience and focused alleviation. This trend reflects a shift in consumer preferences towards therapies that can be easily applied to specific areas of discomfort, enhancing the overall efficacy of pain relief strategies. As awareness of these conditions rises, the market for topical pain relief products continues to expand, catering to the evolving needs of those seeking immediate and accessible solutions for pain alleviation.

Restraints in the Global Topical Pain Relief Market

The global market for topical pain relief products faces a significant challenge stemming from the lack of comprehensive clinical evidence that substantiates their efficacy and safety. This deficiency can undermine consumer confidence and impede widespread adoption, as potential users may be hesitant to rely on these products without substantiated proof from rigorous studies. Consequently, the uncertainty regarding the effectiveness and safety profiles of topical pain relief options can limit their acceptance among both consumers and healthcare providers, presenting a notable restraint in the growth and expansion of this market segment. Addressing this gap is crucial for fostering trust and enhancing product uptake.

Market Trends of the Global Topical Pain Relief Market

The Global Topical Pain Relief market is experiencing a notable trend towards the incorporation of natural and herbal ingredients, reflecting a growing consumer preference for products that emphasize health and wellness. As awareness of synthetic alternatives diminishes, individuals are gravitating towards formulations that harness the power of botanicals, known for their analgesic and anti-inflammatory properties. This shift is driven by a desire for safer, less chemically laden options, prompting manufacturers to innovate and expand their product lines. Consequently, the market is evolving, with an increasing emphasis on transparency, ingredient sourcing, and sustainability, aligning with broader consumer wellness trends.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer And Buying Criteria Analysis
• Regulatory Analysis

Global Topical Pain Relief Market Size by Therapeutic Classes & CAGR (2026-2033)

• Market Overview
• Non-opioids
  • Nonsteroidal anti-inflammatory drug (NSAIDS)
  • Methyl salicylates
  • Capsaicin
  • Lidocaine
  • Other non-opioids
• Opioids
  • Buprenorphine
  • Fentanyl

Global Topical Pain Relief Market Size by Formulation & CAGR (2026-2033)

• Market Overview
• Cream
• Gel
• Spray
• Patch
• Others

Global Topical Pain Relief Market Size by Gender & CAGR (2026-2033)

• Market Overview
• Women
• Men

Global Topical Pain Relief Market Size by Age Group & CAGR (2026-2033)

• Market Overview
• Adults (18-64 Years)
• Geriatric (65 Years and Above)

Global Topical Pain Relief Market Size by Type & CAGR (2026-2033)

• Market Overview
• Prescription Pain Relief
• Over the Counter (OTC) Pain Relief

Global Topical Pain Relief Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Pharmacy and Drug Stores
• Retail Stores
• Online Stores

Global Topical Pain Relief Market Size & CAGR (2026-2033)

• North America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • US
  • Canada
• Europe (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Therapeutic Classes, Formulation, Gender, Age Group, Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (now part of Viatris Inc.) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AdvaCare Pharma (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Topical Biomedics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations